摘要:
The invention relates to a compound of the formula (I) in which: - R 1 represents, independently of each other, a halogen atom; an aliphatic hydrocarbon-based group optionally substituted and/or optionally interrupted by one or more oxygen or sulfur atoms; a nitro group; a cyano group; an amino group; a mono- or dialkylamino group; an alkylcarbonyl group; a carboxyl group; an alkylcarbonylamino group; an alkylsulfonyl group; - R 2 represents, independently of each other, a cyano group; a hydroxyl group, an alkylcarbonyl group; a carboxyl group; an alkoxycarbonyl group; an unsubstituted amide group; or a linear or branched alkyl group substituted by a cyano, hydroxyl, carboxyl, alkoxycarbonyl or unsubstituted amide group; - i and j independently being 1 to 5, with the exclusion of the compound for which i and j = 1 and R 1 = carboxyl and R 2 = alkoxycarbonyl or R 1 = CF 3 and R 2 = carboxyl, and also the pharmaceutically acceptable derivatives, salts, solvates and stereoisomers thereof, including mixtures thereof in all proportions.
摘要:
This invention provides certain compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention are useful as antagonists, or more preferably, partial antagonist of factor IX and thus, may be used to inhibit the intrinsic pathway of blood coagulation. The compounds are useful in a variety of applications including the management, treatment and/or control of diseases caused in part by the intrinsic clotting pathway utilizing factor IX. Such diseases or disease states include stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures, long periods of confinement, and acquired or inherited pro-coagulant states.
摘要:
The present invention provides compounds of Formula I, compositions and methods that are useful for treating viral infections and associated diseases, particularly HCV infections and associated diseases.
摘要:
The present invention provides compounds of Formula I, compositions and methods that are useful for treating viral infections and associated diseases, particularly HCV infections and associated diseases.
摘要:
A process for the preparation of 2-[alkyl(aryl)]sulfonylbenzene sulfonyl chlorides of the formula (I), in which R is alkyl or aryl substituted at the ortho or meta positions with alkyl, aryl, NHAc or alkoxy, comprising the steps of: a) reacting 2-chloronitrobenzene, 2-fluoronitrobenzene or 2-bromonitrobenzene with a compound of the following formula: RSO 2 - M + wherein R is defined above; and M is sodium, potassium, lithium, ammonium or quaternary ammonium, in a polar aprotic solvent at a temperature of about 50 to 190°C; b) reacting the material prepared in step (a) with hydrogen at a pressure of about 20 to about 60 psi in a polar aprotic solvent at a temperature of about 20 to about 60°C; and c) diazotizing the material prepared in step (b) with sodium nitrite in the presence of hydrochloric acid and reacting the resulting diazonium salt with sulfur dioxide in the presence of copper (I) or copper (II) compounds or a mixture thereof, in water.
摘要:
PPAR alpha activators, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipo-protein-cholesterol and to lower certain plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases, in mammals, including humans.
摘要:
This invention relates to new aminoalcohol derivatives or salts thereof represented by formula (I) wherein each symbol is as defined in the specification or salts thereof which have beta 3 adrenergic agonist activity and therefore have gut selective sympathomimetic, anti-ulcerous, anti-pancreatitis, lipolytic, anti-urinary incontinence and anti-pollakiuria activities, to processes for the preparation thereof, to a pharmaceutical composition comprising the same and to a method for the prevention and/or treatment of diseases indicated in the specification to a human being or an animal.
摘要:
The subject invention provides arylhydrazone compounds having formula (I), wherein A and B are independently aryl or heteroaryl and A and B independently are substituted with at least one group selected from alkyl, halogen, CN, COOR , NR R , CONR R , NO2, SR , SOR , SO2R , NHCOR , NHSO2R , OR , hydroxyalkyl, and aminoalkyl. The compounds of this invention are useful for treating a wide variety of bacterial infections, including diseases of the skin, e.g., acne and skin ulcers, gastroenteritis, colitis, meningitis, keratinitis, conjunctivitis, diseases of the urinary and genital tracts, etc.
摘要翻译:本发明提供具有式(I)的芳基腙化合物,其中A和B独立地为芳基或杂芳基,A和B各自独立地被至少一个选自烷基,卤素,CN,COOR 7,NR 7, R 8,CONR 7 R 8,NO 2,SR 7,SOR 7,SO 2 R 7,NHCOR 7,NHSO 2 R 7,OR 7,羟烷基和氨基烷基 。 本发明的化合物可用于治疗各种细菌感染,包括皮肤疾病,例如痤疮和皮肤溃疡,胃肠炎,结肠炎,脑膜炎,角化炎,结膜炎,泌尿系和生殖道疾病等。
摘要:
Sulfonyl compounds of formula (I) in which n is 0, 1 or 2; Y is vinyl or a radical of the formula C2H4Q, where Q is hydroxy or a group separable in alkaline reaction conditions; E is C3-C6 alkylene which may be interrupted by 1 or 2 oxygen atoms in the ether function; Ar is the radical of benzole or naphthalene; and R , R and R are hydrogen, possibly substituted C1-C6 alkyl, C1-C6 alkoxy, hydroxy, halogen, nitro, possibly substituted amino, hydroxysulphonyl, carboxyl, possibly substituted carbamoyl, possibly substituted sulphamoyl, cyano or a radical of the formula (NH-)m(CH2)qSO2-Y, where m is 0 or 1 and q is 0, 2 or 3 and Y has the meaning given above.